We’ve recently updated our valuation analysis.

Signature Bank Valuation

Is SBNY undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SBNY?

Other financial metrics that can be useful for relative valuation.

SBNY key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ratio-0.5x

Price to Earnings Ratio vs Peers

How does SBNY's PE Ratio compare to its peers?

The above table shows the PE ratio for SBNY vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average11.9x
WAL Western Alliance Bancorporation
7.7x9.3%US$8.0b
WBS Webster Financial
14.1x28.6%US$8.8b
CBSH Commerce Bancshares
16.7x0.1%US$8.2b
ZION Zions Bancorporation National Association
9x3.2%US$7.9b
SBNY Signature Bank
6.1x-13.1%US$7.9b

Price-To-Earnings vs Peers: SBNY is good value based on its Price-To-Earnings Ratio (6.1x) compared to the peer average (11.9x).


Price to Earnings Ratio vs Industry

How does SBNY's PE Ratio compare vs other companies in the US Banks Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a6.2%
n/an/an/a

Price-To-Earnings vs Industry: SBNY is good value based on its Price-To-Earnings Ratio (6.1x) compared to the US Banks industry average (9.7x)


Price to Earnings Ratio vs Fair Ratio

What is SBNY's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SBNY PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio6.1x
Fair PE Ratio6.7x

Price-To-Earnings vs Fair Ratio: SBNY is good value based on its Price-To-Earnings Ratio (6.1x) compared to the estimated Fair Price-To-Earnings Ratio (6.7x).


Share Price vs Fair Value

What is the Fair Price of SBNY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SBNY ($127.39) is trading below our estimate of fair value ($196.76)

Significantly Below Fair Value: SBNY is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SBNY forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$127.39
US$147.93
+16.1%
14.8%US$200.00US$113.00n/a14
Jan ’24US$115.22
US$173.69
+50.7%
18.0%US$250.00US$132.00n/a16
Dec ’23US$138.04
US$208.29
+50.9%
20.0%US$350.00US$155.00n/a17
Nov ’23US$160.01
US$219.12
+36.9%
19.1%US$350.00US$176.00n/a17
Oct ’23US$151.00
US$256.82
+70.1%
20.3%US$425.00US$176.00n/a17
Sep ’23US$171.76
US$267.06
+55.5%
16.4%US$425.00US$216.00n/a17
Aug ’23US$183.27
US$267.06
+45.7%
16.4%US$425.00US$216.00n/a17
Jul ’23US$184.12
US$318.59
+73.0%
15.5%US$450.00US$240.00n/a17
Jun ’23US$211.83
US$359.06
+69.5%
17.0%US$472.00US$265.00n/a17
May ’23US$242.25
US$394.94
+63.0%
11.3%US$472.00US$285.00n/a17
Apr ’23US$289.82
US$422.72
+45.9%
10.1%US$480.00US$285.00n/a18
Mar ’23US$316.75
US$430.28
+35.8%
10.8%US$508.00US$285.00n/a18
Feb ’23US$318.63
US$429.83
+34.9%
10.8%US$508.00US$285.00n/a18
Jan ’23US$323.47
US$373.61
+15.5%
11.9%US$475.00US$276.00US$115.2218
Dec ’22US$305.01
US$364.44
+19.5%
10.7%US$410.00US$276.00US$138.0418
Nov ’22US$311.05
US$349.16
+12.3%
10.7%US$405.00US$276.00US$160.0119
Oct ’22US$286.09
US$315.11
+10.1%
9.1%US$375.00US$252.00US$151.0019
Sep ’22US$258.60
US$314.05
+21.4%
9.2%US$375.00US$252.00US$171.7619
Aug ’22US$226.97
US$312.84
+37.8%
8.8%US$375.00US$252.00US$183.2719
Jul ’22US$249.92
US$302.21
+20.9%
9.6%US$375.00US$244.00US$184.1219
Jun ’22US$250.32
US$291.19
+16.3%
8.3%US$350.00US$244.00US$211.8321
May ’22US$251.51
US$287.29
+14.2%
9.0%US$350.00US$243.00US$242.2521
Apr ’22US$225.00
US$252.19
+12.1%
17.2%US$315.00US$165.00US$289.8221
Mar ’22US$223.73
US$222.57
-0.5%
18.2%US$280.00US$155.00US$316.7521
Feb ’22US$166.56
US$181.29
+8.8%
8.2%US$210.00US$150.00US$318.6321
Jan ’22US$135.29
US$140.95
+4.2%
13.3%US$160.00US$100.00US$323.4721

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies